<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00515736</url>
  </required_header>
  <id_info>
    <org_study_id>CE-102-02</org_study_id>
    <nct_id>NCT00515736</nct_id>
  </id_info>
  <brief_title>Impact Of Antioxidant Micronutrients On Intensive Care Unit (ICU) Outcome</brief_title>
  <acronym>Etude-AOX</acronym>
  <official_title>Influence Of Early Antioxidant Supplements On Clinical Evolution And Organ Function In Critically Ill Cardiac Surgery, Major Trauma And Subarachnoid Hemorrhage Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Critically ill patients are generally exposed to an increased oxidative stress, which is
      proportional to the severity of their condition. Endogenous antioxidant (AOX) defenses are
      depleted particularly in those patients with intense inflammatory response. The hypothesis
      tested is that early I:V: administration of a combination of AOX micronutrient supplements
      (Se, Zn, Vit C, Vit E, Vit B1) would improve clinical outcome in selected critically ill
      patients, by reinforcing the endogenous AOX defenses and reducing organ failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective randomized, double-blind, placebo-controlled, single-center trial. Patients
      admitted to ICU after complicated cardiac surgery, major trauma with or without brain injury,
      subarachnoid hemorrhage, and predicted by the clinicians to require &gt;48 hours of ICU
      treatment.

      Supplements: provided IV for 5 days
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    enrollment was completed
  </why_stopped>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">December 2005</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Organ function (SOFA) with special additional attention to renal function</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pneumonia, Length of mechanical ventilation-ICU stay-hospital stay, Mortality</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Critically Ill Patients</condition>
  <condition>Cardiac Surgery</condition>
  <condition>Trauma</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <arm_group>
    <arm_group_label>AOX group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment group - double dose (loading) for 48 hours then single dose (Se 270 mcg, Zn 30 mg, vit C 1.2 g, B1 100 mg, vit E 300 mg enteral)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group receiving vehicle solution for 5 days (double dose for 48 hours)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Selenium (Se), Zinc (Zn), Vitamin C, Vitamin B1, Vitamin E</intervention_name>
    <description>Se 270mcg, Zn 30mg, C 1.1g, B1 100mg, E 300mg</description>
    <arm_group_label>AOX group</arm_group_label>
    <other_name>Selenium - Laboratoire Aguettant</other_name>
    <other_name>Zinc - Laboratoire Aguettant, the others generic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>vehicle</description>
    <arm_group_label>0</arm_group_label>
    <other_name>vehicle - NaCl 0.9% solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients admitted for above diagnosis assessed on admission by the medical team
             likely to require more than 48 hours of ICU

        Exclusion Criteria:

          -  absence of consent, participation in another study, liver cirrhosis or major burns and
             life expectancy &lt; 24 hours or a lack of commitment to full aggressive care
             (anticipated withholding or withdrawing treatments in the 48 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mette M Berger, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dpt of Adult Intensive Care, CHUV</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dpt of Adult Intensive Care - CHUV</name>
      <address>
        <city>Lausanne</city>
        <state>VD</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Berger MM, Soguel L, Shenkin A, Revelly JP, Pinget C, Baines M, Chiol√©ro RL. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care. 2008;12(4):R101. doi: 10.1186/cc6981. Epub 2008 Aug 7.</citation>
    <PMID>18687132</PMID>
  </results_reference>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2007</study_first_submitted>
  <study_first_submitted_qc>August 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2007</study_first_posted>
  <last_update_submitted>July 29, 2010</last_update_submitted>
  <last_update_submitted_qc>July 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof Mette M Berger, MD, PhD</name_title>
    <organization>Dept of Adult Intensive Care, CHUV</organization>
  </responsible_party>
  <keyword>selenium</keyword>
  <keyword>oxidative stress</keyword>
  <keyword>glutathione peroxidase</keyword>
  <keyword>critically ill</keyword>
  <keyword>outcome</keyword>
  <keyword>supplementation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Thiamine</mesh_term>
    <mesh_term>Antioxidants</mesh_term>
    <mesh_term>Selenium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

